Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Prostatic Neoplasms 112Lymphoma 66Lymphoma, Large B-Cell, Diffuse 50Precursor Cell Lymphoblastic Leukemia-Lymphoma 31Lymphoma, Non-Hodgkin 29Lymphoma, Follicular 22Burkitt Lymphoma 22Multiple Myeloma 19Leukemia 16Hodgkin Disease 16Neoplasms 14Neoplasm Metastasis 13Lymphoma, B-Cell 13Lymphoma, Mantle-Cell 11Lymphoma, Large-Cell, Anaplastic 11Lymphoma, T-Cell 8Lymphoma, B-Cell, Marginal Zone 8Lymphoma, T-Cell, Peripheral 7Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6Hematologic Neoplasms 5Waldenstrom Macroglobulinemia 4Recurrence 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, AIDS-Related 4Immunoblastic Lymphadenopathy 4Prostate Cancer Metastatic 3Primary Myelofibrosis 3Polycythemia Vera 3Plasmablastic Lymphoma 3Parkinson Disease 4, Autosomal Dominant Lewy Body 3

Interventions

nintedanib 2durvalumab 1Prednisone 1Immunoglobulin G 1Enalapril 1Disulfides 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Radiation Pneumonitis × Prednisone × Clear all
NCT02496585 2025-04-16

Study to Evaluate the Efficacy and Safety of Nintedanib (BIBF 1120) + Prednisone Taper in Patients With Radiation Pneumonitis

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
34 enrolled 10 charts
Thoracic

Lung Neoplasms, Radiation Pneumonitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡